Company Registration number: 02141700

Camelot Care (Plymouth) Limited

Contents

Company Information	1
Strategic Report	2 to 3
Director's Report	4
Statement of Director's Responsibilities	5
Independent Auditor's Report	6 to 9
Profit and Loss Account	10
Statement of Comprehensive Income	11
Balance Sheet	12
Statement of Changes in Equity	13
Notes to the Financial Statements	14 to 25

Camelot Care (Plymouth) Limited

Company Information

Director

P I Teasdale

Company secretary

P I Teasdale

Registered office

Suite 106 C/O Walpole Dunn Viney Court Viney Street Taunton Somerset TA1 3FB

Auditors

Albert Goodman LLP 5th Floor 25 King Street Bristol BS1 4PB

Camelot Care (Plymouth) Limited

Strategic Report for the Year Ended 31 December 2025

The director presents his strategic report for the year ended 31 December 2025.

Principal activity

The principal activity of the company is the operation of a nursing home.

Fair review of the business

Turnover of £2,643,689 (2024: £2,451,955) was converted into a profit for the year, after taxation, of £414,281 (2024: £467,146).

The company has continued strong trading performance despite the increase in the National Living Wage and continued high administrative and establishment costs.

The company recognises the importance of its workforce and continues to prioritise staffing and recruitment, as well as investing in infrastructure and equipment to ensure the delivery of the highest level of care for our residents.

The management of costs whilst ensuring appropriate weekly rates and high levels of occupancy has been key to ensuring strong trading performance throughout the year.

The director is confident that the approach of reinvesting profits in the company will mean that the home is well placed to consolidate its position in the region as a key strategic partner for the local authority as well as attracting self-funders to its homes through its reputation for delivering high-quality care.

Our key aim above all is to provide outstanding care to our service users in a safe and welcoming environment for residents, their families, and employees.

The home specialises in providing care to people who have dementia and other mental health needs. To help ensure the excellence of our service we monitor and focus on:

1. The provision of high-quality care and support, measured by internal assessments and external confirmation, including the Care Quality Commission (CQC) inspections and reports.

2. Recruitment and retention of quality staff, measured in terms of customer feedback, staff turnover and our success and investment in training our employees with an aim of enhancing the number of staff holding nationally accredited qualifications in care.

3. Maintenance of high levels of occupancy.

Principal risks and uncertainties

The principal risks and uncertainties of the company are:

1. CQC regulation: the health, safety and other regulatory requirements as outlined by the CQC. The group strives to mitigate these risks by providing excellent care to its residents and ensuring its care procedures are continually monitored and updated through regular quality assessment.

2. Interest rate and compliance with banking covenants risk: The group has financed its operations through a mix of short- and medium-term borrowings and available cash balances. The director monitors the interest rate risk and ongoing covenants compliance.

Camelot Care (Plymouth) Limited

Strategic Report for the Year Ended 31 December 2025

Approved by the Board on 24 September 2026 and signed on its behalf by:

P I Teasdale Company secretary and director

Camelot Care (Plymouth) Limited

Director's Report for the Year Ended 31 December 2025

The director presents his report and the financial statements for the year ended 31 December 2025.

Director of the company

The director who held office during the year was as follows:

P I Teasdale - Company secretary and director

Financial instruments

Objectives and policies

The company's principal financial instruments comprise bank balances, bank loans, trade creditors, trade debtors and group receivables and payables. The main purpose of these instruments is to manage funds to finance the company's operations.

Price risk, credit risk, liquidity risk and cash flow risk

Due to the nature of the financial instruments used by the company there is no exposure to price risk. The company's approach to managing other risks applicable to the financial instruments concerned is shown below.

In respect of bank balances, the liquidity risk is managed by maintaining a balance between the continuity of funding and loans from financial institutions. The interest rate on the loans from financial institutions is variable but the monthly repayments are fixed.

The company manages the liquidity risk by ensuring there are sufficient funds to meet the payments.

Trade debtors are managed in respect of credit and cash flow risk by policies concerning the credit offered to customers and the regular monitoring of amounts outstanding for both time and credit limits.

Trade creditors liquidity risk is managed by ensuring sufficient funds are available to meet amounts due.

Disclosure of information to the auditors

The director has taken steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information. The director confirms that there is no relevant information that he knows of and of which he knows the auditors are unaware.

Future Developments

The future developments of the business are included within the strategic report.

Approved by the Board on 24 September 2026 and signed on its behalf by:

P I Teasdale Company secretary and director

Camelot Care (Plymouth) Limited

Statement of Director's Responsibilities

The director acknowledges his responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

•	select suitable accounting policies and apply them consistently;

•	make judgements and accounting estimates that are reasonable and prudent;

•	state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

•	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Camelot Care (Plymouth) Limited

Independent Auditor's Report to the Members of Camelot Care (Plymouth) Limited

Opinion

We have audited the financial statements of Camelot Care (Plymouth) Limited (the 'company') for the year ended 31 December 2025, which comprise the Profit and Loss Account, Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

•	give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;
•	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
•	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Camelot Care (Plymouth) Limited

Independent Auditor's Report to the Members of Camelot Care (Plymouth) Limited

Other information

The director are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

•	the information given in the Strategic Report and Director's Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

•	the Strategic Report and Director's Report have been prepared in accordance with applicable legal requirements.

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Director's Report.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

•	adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
•	the financial statements are not in agreement with the accounting records and returns; or
•	certain disclosures of director's remuneration specified by law are not made; or
•	we have not received all the information and explanations we require for our audit.

Responsibilities of the director

As explained more fully in the Statement of Director's Responsibilities set out on page 5, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Camelot Care (Plymouth) Limited

Independent Auditor's Report to the Members of Camelot Care (Plymouth) Limited

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

The extent to which the audit was considered capable of detecting irregularities including fraud

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

•	the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
•	we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the care sector;
•	we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, taxation legislation, employment, environmental, health and safety legislation, and the CQC requirements;
•	we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and
•	identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

•	making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and
•	considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:

•	performed analytical procedures to identify any unusual or unexpected relationships;
•	tested journal entries to identify unusual transactions;
•	assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias; and
•	investigated the rationale behind significant or unusual transactions.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

Camelot Care (Plymouth) Limited

Independent Auditor's Report to the Members of Camelot Care (Plymouth) Limited

•	agreeing financial statement disclosures to underlying supporting documentation;
•	enquiring of management as to actual and potential litigation and claims; and
•	reviewing correspondence with HMRC, relevant regulators including the Health and Safety Executive, and the company’s legal advisors.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Neil Johnston (Senior Statutory Auditor)
For and on behalf of Albert Goodman LLP, Statutory Auditor

5th Floor
25 King Street
Bristol
BS1 4PB

24 September 2026

Camelot Care (Plymouth) Limited

Profit and Loss Account
for the Year Ended 31 December 2025

	Note	2025  £	2024  £
Turnover	3	2,643,689	2,451,955
Cost of sales		(1,751,247)	(1,624,410)
Gross profit		892,442	827,545
Administrative expenses		(324,918)	(269,426)
Other operating income	4	2,442	20,109
Operating profit	5	569,966	578,228
Reversal of depreciation on revaluation		-	50,022
Other interest receivable and similar income		4,486	-
Interest payable and similar charges	6	(53,122)	(39,451)
Profit before tax		521,330	588,799
Taxation	10	(108,258)	(121,653)
Profit for the financial year		413,072	467,146

The above results were derived from continuing operations.

Camelot Care (Plymouth) Limited

Statement of Comprehensive Income
for the Year Ended 31 December 2025

	2025 £	2024 £
Profit for the year	413,072	467,146
Surplus on property, plant and equipment revaluation	-	372,997
Deferred tax relating to other comprehensive income	-	(64,817)
	-	308,180
Total comprehensive income for the year	413,072	775,326

Camelot Care (Plymouth) Limited

(Registration number: 02141700)
Balance Sheet as at 31 December 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	11	3,489,435	3,500,000
Current assets
Debtors	12	3,018,592	1,924,759
Cash at bank and in hand		117,240	247,191
		3,135,832	2,171,950
Creditors: Amounts falling due within one year	14	(207,597)	(218,717)
Net current assets		2,928,235	1,953,233
Total assets less current liabilities		6,417,670	5,453,233
Creditors: Amounts falling due after more than one year	14	(984,615)	(434,459)
Provisions for liabilities	15	(551,591)	(550,382)
Net assets		4,881,464	4,468,392
Capital and reserves
Called up share capital		100	100
Revaluation reserve		1,883,824	1,883,824
Retained earnings		2,997,540	2,584,468
Shareholders' funds		4,881,464	4,468,392

Approved and authorised by the director on 24 September 2026
 

P I Teasdale Company secretary and director

Camelot Care (Plymouth) Limited

Statement of Changes in Equity
for the Year Ended 31 December 2025

	Share capital £	Revaluation reserve £	Retained earnings £	Total £
At 1 January 2025	100	1,883,824	2,584,468	4,468,392
Profit for the year	-	-	413,072	413,072
At 31 December 2025	100	1,883,824	2,997,540	4,881,464